Mastologia

Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention.

JAMA oncology. 2025 Jul; doi: 10.1001/jamaoncol.2025.2203. pii: .

The Effect of Oncoplastic Reduction Mammoplasty on the Incidence of Breast Lymphedema in Women Undergoing Breast Conservation Surgery.

Annals of surgical oncology. 2025 Jul; doi: 10.1245/s10434-025-17839-z. pii: .

Breast Cancer Upstaging Risk and In Vivo Tumor Growth Rates Associated with Preoperative Delays.

Annals of surgical oncology. 2025 Jul; doi: 10.1245/s10434-025-17867-9. pii: .

Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Jul; JCO2402697. doi: 10.1200/JCO-24-02697. pii: .

Underdiagnosis of breast malignancy: Azzopardi's Problems in Breast Pathology revisited, part II.

Seminars in diagnostic pathology. 2025 Jul; 42(Jul):150875. doi: 10.1053/j.semdp.2025.02.002. pii: S0740-2570(25)00010-3.

Overdiagnosis of breast malignancy: Azzopardi's Problems in Breast Pathology revisited, Part I.

Seminars in diagnostic pathology. 2025 Jul; 42(Jul):150874. doi: 10.1053/j.semdp.2025.02.001. pii: S0740-2570(25)00011-5.

Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands.

Leukemia & lymphoma. 2025 Jul; 1-7. doi: 10.1080/10428194.2025.2530167. pii: .

Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial.

British journal of cancer. 2025 Jul; doi: 10.1038/s41416-025-03097-z. pii: .

Improved evaluation of patients with small clusters of microcalcifications on mammograms: Implementation of vacuum assisted excision with "cavity margins shaving" technique.

European journal of radiology. 2025 Jul; 188(Jul):112138. doi: 10.1016/j.ejrad.2025.112138. pii: S0720-048X(25)00224-4.

Diagnostic accuracy of sentinel lymph node biopsy and wire localized clipped node biopsy after neoadjuvant chemotherapy in node-positive breast cancer.

Surgery today. 2025 Feb; 55(Feb):172-179. doi: 10.1007/s00595-024-02981-0. pii: .

ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.

Annals of surgical oncology. 2025 Apr; 32(Apr):2612-2613. doi: 10.1245/s10434-025-16952-3. pii: .

The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025 Feb; 51(Feb):109689. doi: 10.1016/j.ejso.2025.109689. pii: S0748-7983(25)00117-9.

Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial.

The Lancet. Oncology. 2025 Jan; 26(Jan):37-50. doi: 10.1016/S1470-2045(24)00661-2. pii: S1470-2045(24)00661-2.

Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma.

Annals of surgical oncology. 2025 Jun; doi: 10.1245/s10434-025-17735-6. pii: .

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.

The New England journal of medicine. 2025 Jun; 392(Jun):2113-2124. doi: 10.1056/NEJMoa2414859. pii: .

Great Debate: Does Breast-Conserving Surgery with Radiotherapy Offer Better Survival than Mastectomy in Early-Stage Breast Cancer?

Annals of surgical oncology. 2025 Jul; 32(Jul):4590-4596. doi: 10.1245/s10434-025-17333-6. pii: .

Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Jun; 43(Jun):1948-1960. doi: 10.1200/JCO-24-01739. pii: .

Limitations of locoregional and distant recurrence analysis after neoadjuvant chemotherapy.

Breast cancer research and treatment. 2025 Jul; 212(Jul):183-184. doi: 10.1007/s10549-025-07680-z. pii: .

Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers.

Cancer. 2025 Jun; 131(Jun):e35910. doi: 10.1002/cncr.35910. pii: e35910.

Second-Look Ultrasound: When Things Are Not Always as They Seem.

Ultrasound quarterly. 2025 Jun; 41(Jun):doi: 10.1097/RUQ.0000000000000715. pii: e00715.

HER2 testing: evolution and update for a companion diagnostic assay.

Nature reviews. Clinical oncology. 2025 Apr; doi: 10.1038/s41571-025-01016-y. pii: .

A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).

Journal of surgical oncology. 2025 May; doi: 10.1002/jso.28159. pii: .

Liquid biopsy in breast cancer: a practical guide for surgeons.

Gland surgery. 2025 Apr; 14(Apr):754-760. doi: 10.21037/gs-2025-11. pii: .

Evaluation of pathological complete response rates in breast cancer patients undergoing neoadjuvant therapy.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2025 ; 47():doi: 10.61622/rbgo/2025rbgo13. pii: e-rbgo13.

HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.

NPJ breast cancer. 2025 Apr; 11(Apr):37. doi: 10.1038/s41523-025-00753-8. pii: 37.

Age to Initiate Routine Breast Cancer Screening: ACOG Clinical Practice Update.

Obstetrics and gynecology. 2025 Jan; 145(Jan):e40-e44. doi: 10.1097/AOG.0000000000005757. pii: .

Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 1: The role of common errors in radiology in missed breast cancer and implications of misdiagnosis.

European radiology. 2024 Nov; doi: 10.1007/s00330-024-11128-1. pii: .

Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.

European radiology. 2024 Nov; doi: 10.1007/s00330-024-11133-4. pii: .

Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.

Cancer. 2024 Oct; 130(Oct):3251-3271. doi: 10.1002/cncr.35389. pii: .

Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines.

Breast (Edinburgh, Scotland). 2024 Dec; 78(Dec):103806. doi: 10.1016/j.breast.2024.103806. pii: 103806.

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Aug; 34(Aug):645-659. doi: 10.1016/j.annonc.2023.05.008. pii: S0923-7534(23)00693-2.

Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.

Annals of surgical oncology. 2024 Sep; 31(Sep):5479-5482. doi: 10.1245/s10434-024-15638-6. pii: .

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756.

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Jul; 22(Jul):331-357. doi: 10.6004/jnccn.2024.0035. pii: .

Intensity Modulated Therapy for Patients With Breast Cancer. Practical Guidelines and Tips for an Effective Treatment Planning Strategy.

Advances in radiation oncology. 2024 Aug; 9(Aug):101535. doi: 10.1016/j.adro.2024.101535. pii: 101535.

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.

Practical radiation oncology. 2024 ; 14():112-132. doi: 10.1016/j.prro.2023.11.001. pii: S1879-8500(23)00296-5.

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.

Annals of surgical oncology. 2024 Oct; 31(Oct):7326-7334. doi: 10.1245/s10434-024-15713-y. pii: .

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Feb; 42(Feb):584-604. doi: 10.1200/JCO.23.02225. pii: .

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology. 2024 Feb; 35(Feb):159-182. doi: 10.1016/j.annonc.2023.11.016. pii: S0923-7534(23)05104-9.

Challenges of breast cancer screening.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Sep; 45(Sep):551-554. doi: 10.1055/s-0043-1775931. pii: .

Challenges of breast cancer screening.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Oct; 45(Oct):622-625. doi: 10.1055/s-0043-1776716. pii: .

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.

Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Sep; 21(Sep):900-909. doi: 10.6004/jnccn.2023.0046. pii: .

New US breast cancer screening recommendations.

The Lancet. Oncology. 2023 Jun; 24(Jun):e242. doi: 10.1016/S1470-2045(23)00238-3. pii: S1470-2045(23)00238-3.

European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024 Jan; 50(Jan):107292. doi: 10.1016/j.ejso.2023.107292. pii: S0748-7983(23)00930-7.

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.

The Lancet. Oncology. 2024 Feb; 25(Feb):e73-e83. doi: 10.1016/S1470-2045(23)00534-X. pii: S1470-2045(23)00534-X.

NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.

Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Jun; 21(Jun):594-608. doi: 10.6004/jnccn.2023.0031. pii: .

Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.

Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Nov; 34(Nov):970-986. doi: 10.1016/j.annonc.2023.08.017. pii: S0923-7534(23)00835-9.

Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper.

Clinical breast cancer. 2023 Oct; 23(Oct):e458-e469. doi: 10.1016/j.clbc.2023.07.006. pii: S1526-8209(23)00202-1.

Recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para rastreamento do câncer de mama por métodos de imagem

Radiol Bras. 2023 Jul/Ago;56(4):207–214.

ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC).

Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Oct; 34(Oct):849-866. doi: 10.1016/j.annonc.2023.08.001. pii: S0923-7534(23)00798-6.

Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention.

JAMA oncology. 2025 Jul; doi: 10.1001/jamaoncol.2025.2203. pii: .

Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.

Annals of surgical oncology. 2025 Jul; doi: 10.1245/s10434-025-17862-0. pii: .

Breast Cancer Upstaging Risk and In Vivo Tumor Growth Rates Associated with Preoperative Delays.

Annals of surgical oncology. 2025 Jul; doi: 10.1245/s10434-025-17867-9. pii: .

The Effect of Oncoplastic Reduction Mammoplasty on the Incidence of Breast Lymphedema in Women Undergoing Breast Conservation Surgery.

Annals of surgical oncology. 2025 Jul; doi: 10.1245/s10434-025-17839-z. pii: .

Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands.

Leukemia & lymphoma. 2025 Jul; 1-7. doi: 10.1080/10428194.2025.2530167. pii: .

Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Jul; JCO2402697. doi: 10.1200/JCO-24-02697. pii: .

Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial.

British journal of cancer. 2025 Jul; doi: 10.1038/s41416-025-03097-z. pii: .

Underdiagnosis of breast malignancy: Azzopardi's Problems in Breast Pathology revisited, part II.

Seminars in diagnostic pathology. 2025 Jul; 42(Jul):150875. doi: 10.1053/j.semdp.2025.02.002. pii: S0740-2570(25)00010-3.

How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?

Breast cancer research and treatment. 2025 Jul; 212(Jul):13-21. doi: 10.1007/s10549-025-07642-5. pii: .

Improved evaluation of patients with small clusters of microcalcifications on mammograms: Implementation of vacuum assisted excision with "cavity margins shaving" technique.

European journal of radiology. 2025 Jul; 188(Jul):112138. doi: 10.1016/j.ejrad.2025.112138. pii: S0720-048X(25)00224-4.